Imetelstat
Orphan Drug Cold Chain RequiredFDA Approved (2024)
Contents
Description
A first-in-class telomerase inhibitor for transfusion-dependent anemia in lower-risk myelodysplastic syndromes. FDA-approved June 2024.
Indications & Therapeutic Use
Lower-risk myelodysplastic syndromes
Linked Diseases:
Global Availability (1 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| Standard Marketing Authorization | — | — | Approved |
Buy / Source Imetelstat — GNH India
4 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Imetelstat products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Imetelstat
| Generic Name | imetelstat |
| Brands | 1 brand available |
| Active Ingredient | imetelstat |
| Drug Class | Lower-risk myelodysplastic syndromes |
| Manufacturer | Geron Corporation |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Reg. Status | FDA Approved (2024) |
| Countries | 1 countries |
Authority Signals
Last Verified7/24/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations2 Validated Nodes